Tuesday brought a sharp rally in the broad market, with the S&P 500 climbing 1.76% to close at 754.83. But beneath that headline gain lies a market splitting hard: mega-cap tech and blue chips are carrying the load, while the small-cap and specialty-ETF world is in freefall.
Market movers
|
S&P 500
754.83
+1.76%
|
Nasdaq 100
—
—
|
Dow Jones
—
—
|
Russell 2000
—
—
|
Volatility
—
—
|
| RGNT | Regentis Biomaterials Ltd. | 9.40 | +526.67% |
| CAST | FreeCast, Inc. Class A Common Stock | 3.75 | +141.94% |
| AREB | American Rebel Holdings, Inc. | 0.18 | +125.64% |
| CUPR | Cuprina Holdings (Cayman) Limited Class A Ordinary Shares | 8.41 | +111.84% |
| VSME | VS Media Holdings Limited Class A Ordinary Shares | 3.25 | +92.31% |
| QGRD | Horizon Nasdaq-100 Defined Risk ETF | 30.61 | -98.02% |
| SPCK | SPAC and New Issue ETF | 22.19 | -86.21% |
| ELTX | Elicio Therapeutics, Inc. | 4.08 | -72.53% |
| MLAC | Mountain Lake Acquisition Corp. | 1.16 | -62.82% |
| CNTX | Context Therapeutics Inc. | 0.68 | -51.14% |
The day's gainers read like a penny-stock fever dream—RGNT up 527%, CAST up 142%, AREB up 126%—the kind of moves that arrive with zero news and depart with zero explanation. On the flip side, the losers are brutal: QGRD (a Nasdaq-100 defined-risk ETF) down 98%, SPCK down 86%, and a cluster of biotech and blank-check names imploding. The S&P's resilience suggests the big names are holding the tape up while the edges burn off.
The Daily Dollar is auto-generated for informational and educational purposes only. Nothing here is financial advice, a recommendation to buy or sell, or a forecast. Markets are risky; do your own research.